Visualitza per autor "Ramalingam, Suresh"
Ara mostrant els elements 1-2 d 2
-
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
Yang, James Chih-Hsin; Jänne, Pasi A.; Ramalingam, Suresh; Kim, Tae Min; Riely, Gregory; FELIP, ENRIQUETA; Zhou, Caicun (Taylor & Francis, 2023) -
Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design
Riely, Gregory; Ahn, Myung-Ju; Felip Font, Enriqueta; Ramalingam, Suresh; Tsao, Anne; Smit, Egbert (Future Medicine, 2022-03)